Oral probiotic treatment of Lactobacillus rhamnosus Lcr35® prevents visceral hypersensitivity to a colonic inflammation and an acute psychological stress.
Y DarbakyB EvrardS PatrierJ FalentaS GarcinA TridonM DapoignyC SilberbergAdrien NivoliezL DiopPublished in: Journal of applied microbiology (2016)
Two formulas of Lcr35® probiotic strain show very encouraging results for the treatment of IBS patients. Further studies are needed to better understand the role and mechanisms of probiotics on the pathogenesis of IBS.